MEGIN
  • About us
  • MEG Maps™
    • What is MEG Maps™
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts & Studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
    • MEGIN Community
  • Community
  • China
Select Page
MEGIN joins over 30 UK HealthTech pioneers on ABHI mission to bolster trade ties in California

MEGIN joins over 30 UK HealthTech pioneers on ABHI mission to bolster trade ties in California

by MEGIN | Sep 14, 2022 | MEGIN News

MEGIN is delighted to be among the delegates of leading UK innovators heading to California this week (12-16 September 2022) as part of ABHI’s mission to bolster trade partnerships and promote the strengths of UK HealthTech stateside. The visit builds on the successes...
MEGIN joins over 20 UK HealthTech innovators on ABHI mission to strengthen trade partnerships in Tennessee

MEGIN joins over 20 UK HealthTech innovators on ABHI mission to strengthen trade partnerships in Tennessee

by MEGIN | Jul 25, 2022 | MEGIN News

This month, MEGIN is delighted to be among the delegate of leading UK HealthTech innovators heading to Tennessee to strengthen trade links and showcase their products and services to the US market. The visit marks the second major US trade mission organised this year...
MEG for presurgical evaluation

MEG for presurgical evaluation

by MEGIN | Jun 22, 2022 | Masterclass - Clinical MEG

Presented by Dr. Stefan...
FLUX: A pipeline for MEG analysis supported by code and examples

FLUX: A pipeline for MEG analysis supported by code and examples

by MEGIN | May 26, 2022 | Masterclass - Data Acquisition and Analysis

Presented by Oscar Ferrante and Ole...
MEGIN joins 28 UK HealthTech pioneers on ABHI mission to strengthen trade relations in Texas

MEGIN joins 28 UK HealthTech pioneers on ABHI mission to strengthen trade relations in Texas

by MEGIN | Mar 22, 2022 | MEGIN News

MEGIN is excited to be among the delegate of pioneering HealthTech companies heading to Texas as part of the first major US trade mission organized by the Association of British HealthTech Industries (ABHI) since the COVID-19 pandemic. The visit marks the launch of a...
« Older Entries
Next Entries »

Subscribe to MEGIN Matters

Don't miss the latest MEG insights and MEGIN news - complete the form below to be added to our mailing list and receive MEGIN Matters right in your inbox!

Join Our Mailing List

Home
About us

MEG Maps™
Careers
Contact us
Join Our Mailing List

Insights & education
News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

MEGIN Community

Patients

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2025© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.

Subscribe to MEGIN Matters

Don’t miss the latest MEG insights and MEGIN news – complete the form below to be added to our mailing list and receive MEGIN Matters right in your inbox!